Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?. J. Can. Res. Updates. 2013;2(4): 297-305. doi:10.6000/1929-2279.2013.02.04.8